Value-Based Contracting For Psychotherapy: The New Normal?
Previous attempts to reduce costs have failed and Healthplan profits have increased.
Part of the reason for the failures of attempts at reducing cost has been a lack of appropriate and accountable incentives for care providers.
Cost control efforts like utilization review provide little or no focus on quality of care.
By the end of 2020, federal debt held by the public is projected to equal 98 percent of GDP. The projected budget deficits would boost federal debt to 104 percent of GDP in 2021, to 107 percent of GDP (the highest amount in the nation’s history) in 2023, and to 195 percent of GDP by 2050. If current laws generally remain in place, net outlays for those programs would increase to 9.2 percent in 2050.
Finding ways to make significant changes to the way in which the government and employers finance health care has proven difficult. Healthcare policy makers’ efforts to slow this rapid growth will prove difficult using traditional Healthcare contracting strategies. Previous attempts to reduce costs have failed and Healthplan profits have generally increased. Part of the reason for the failures of attempts at reducing cost has been a lack of appropriate and accountable incentives for care providers. Cost control efforts like utilization review provide little or no focus on quality of care. These efforts fail because the policies create incentives to limit care (sometimes advisable or necessary care). Alternatively, Healthplans simply reduce the price they are willing to pay for services, again without regard to quality.
These perverse attempts by Healthplan to reduce costs have included lowering compensation for psychotherapy services with the effect of increasing the volume of services from other Healthplans. In those communities, psychotherapists start focusing their marketing on out-of-pocket services to maintain revenue.
A return to out-of-pocket services practice exclusively is not viable for an entire profession. Only a small number will attract a high number of patients. And calls to boycott a Healthplan that pursues value-based contracts are illegal.
Strategies that limiting care leads to greater health problems or patient seeking medical care for psychological distress. Healthplans with higher than average reimbursements know that their patients are being seen longer than those plans that pay providers a lower rate. Yet many Healthplans that pay lower rates see no point in auditing psychotherapists and allow providers to see their patient longer before questioning the medical necessity of care.
Health insurance in Oregon is currently providing health care services at higher levels in terms of quantity. A consequence of Oregon House Bill 3046, Healthplans will be subject to normalized comparisons of psychotherapists and Healthplans. This law will likely have an equalizing effect on the cost of mental health services. By requiring normalized psychotherapy reimbursements, Healthplans can more easily, and with greater certainty (lower risk), develop and offer value-based psychotherapy services. As a result of the pandemic, and HB 3046, value-based contracts are more important and also more feasible.
Even after the effects of the 2020 coronavirus pandemic fade, economic deficits are projected to be huge in coming decades. The Congressional Budget Office (CBO) projects deficits will increase from 5 percent of gross domestic product (GDP) in 2030 to 13 percent by 2050—larger in each year than the average deficit increase of 3 percent of GDP over the past 50 years.
The Oregon Healthplan and commercial Healthplans are seeking models for high-value health care services that can contribute in a meaningful way to manage costs. Healthplans want to reduce costs, increase the quality of care, and maintain an acceptable level of profit. The value they wish to contract for are measurable outcomes using processes that reduce cost, increase their profits and offer their customers a competitive value proposition (i.e. quality of care). As they have failed to accomplish this by restricting care, they are now forced consider incentives and rewards for those providers who will accept lower, the same or greater reimbursements.
Value-Based Contracting is already in use in the health care economy, primarily Medicaid and Medicare. Commercial versions are now being developed in Oregon. Several Federal and Oregon State funded versions have been in operation for nearly 10 years. If we assume utilization review and cutting fee-for-service will not contain costs in psychotherapy services, then the only avenue that remains is for Healthplans to offer or require value-based contracts.
References
Congress of the United States. Congressional Budget Office. The 2017 long-term budget outlook. Available at: https://www.cbo.gov/publication/56598#:~:text=In%20CBO's%20projections%2C%20federal%20debt,time%20as%20the%20economy%20expands. Accessed July 25, 2021.
Millenson ML. Half a century of the health care crisis (and still going strong). Health Affairs blog. September 12, 2018. Available at: www.healthaffairs.org/do/10.1377/hblog20180904.457305/full/. Accessed April 14, 2021.
Huron Consulting Group Inc. Value-based contracting in the U.S. Available at: www.huronconsultinggroup.com/insights/value-based-contracting-in-us. Accessed April 14, 2021.
Thomas Smith, Robert Myers, Lloyd Sederer, & Joshua Berezin. How Value-Based Payment Arrangements Should Measure Behavioral Health
https://www.healthaffairs.org/do/10.1377/hblog20161129.057660/full/ Accessed 2021
Marlene Maheu & Myron L. Pulier, MD. Caution: Direct-to-Consumer Digital Care – All That Glitters Is Not Gold:
https://www.telehealth.org/digital-care/ Accessed December 2021
Stoddard Davebport, T. J. Gray and Steve Melek. How do individual with behavioral health conditions contribute to physical and total healthcare spending?
https://www.milliman.com/-/media/milliman/pdfs/articles/milliman-high-cost-patient-study-2020.ashx Accessed 2020
Hayley Roger, Charlie Mills, & Mathew Kramer. Estimating the impact of COVID-19 on HealthCare costs in 2020. https://www.milliman.com/-/media/milliman/pdfs/articles/estimating-the-financial-impact-covid19.ashx
Stoddard Davenport, Steve Melek & T. J. Gray. Behavioral healthcare utlization changes during the COVID-19 Pandemic. https://wellbeingtrust.org/wp-content/uploads/2021/03/Milliman-COVID-BH-Impact-2021-02-17.pdf Accessed December 2021
Julia Alexandra Dunn , Hélène Chokron Garneau, Heather Filipowicz, Megan Mahoney, Timothy Seay-Morrison, Kaitlin Dent, and Mark McGovern. What Are Patient Preferences for Integrated Behavioral Health in Primary Care? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543553/pdf/10.1177_21501327211049053.pdf Accessed 2021